Showing results (671-680 of 993) with videos related to
Sort By:
Pageof 100
Life Sciences|December 24, 1984
Steroid antagonism of the 'hypertensinogenic' activity of 9 alpha-fluoroprednisoloneJ P Coghlan, D A Denton, E H Mills, et al.Clinical and Experimental Pharmacology & Physiology|November 1, 1984
Demonstration of alpha-adrenoceptor antagonism by the 5HT2 antagonist, ketanserin (R49945), in sheepM A Nelson, J P Coghlan, D A Denton, et al.Clinical and Experimental Pharmacology & Physiology|November 1, 1985
The effect of the 'hypertensinogenic' steroid, 9 alpha-fluorocortisol on blood pressure in sheep with ACTH-induced hypertensionE H Mills, J P Coghlan, D A Denton, et al.Journal of Clinical Pathology|March 1, 2003
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel diseaseA Giatromanolaki, E Sivridis, E Maltezos, et al.Lancet (London, England)|January 27, 1990
Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancerA L Harris, B M Cantwell, J Carmichael, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failureS Nicholson, C Wright, J R Sainsbury, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic responseJ Carmichael, B M Cantwell, C M Edwards, et al.The Journal of Pathology|January 1, 1992
Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomasJ Cairns, C Wright, A R Cattan, et al.BJU International|July 25, 2000
Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testisA Jones, C Fujiyama, K Turner, et al.Cancer Research|September 15, 1993
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancerS B Fox, K C Gatter, R Bicknell, et al.Pageof 100